Literature DB >> 12403365

Varied biologic functions of C-reactive protein: lessons learned from transgenic mice.

Alexander J Szalai1, Mark A McCrory.   

Abstract

Our investigations of human C-reactive protein (CRP) and CRP transgenic mice have produced novel data that firmly establish this protein as an important host defense molecule. For example, we have learned that depending on the disease model, the beneficial effect of CRP can be direct, depend on the protein's ability to engage complement and Fcy receptors, or rely on its ability to bridge innate and adaptive immunity. In addition, the degree of protection correlates with acute phase expression, but more important, also with the amount of CRP expressed constitutively. Furthermore, differences in baseline levels of CRP among healthy individuals and among patients can be attributed to a CRP gene polymorphism. In this article, we discuss these and other observations we have made during the last 5 yr and summarize our ongoing studies and future plans related to CRP biology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403365     DOI: 10.1385/IR:26:1-3:279

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  28 in total

Review 1.  Regulation of complement activation by C-reactive protein.

Authors:  C Mold; H Gewurz; T W Du Clos
Journal:  Immunopharmacology       Date:  1999-05

2.  Dinucleotide repeat polymorphism at the CRP locus.

Authors:  J L Weber; A E Kwitek; P E May
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

3.  Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage.

Authors:  E Lutgens; M Daemen; M Kockx; P Doevendans; M Hofker; L Havekes; H Wellens; E D de Muinck
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

4.  The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice.

Authors:  R W Burlingame; M A Volzer; J Harris; T W Du Clos
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

5.  Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component.

Authors:  A J Szalai; F W van Ginkel; Y Wang; J R McGhee; J E Volanakis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

6.  Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein.

Authors:  Alexander J Szalai; Serge Nataf; Xian-Zhen Hu; Scott R Barnum
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

7.  Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component.

Authors:  P Woo; J R Korenberg; A S Whitehead
Journal:  J Biol Chem       Date:  1985-10-25       Impact factor: 5.157

8.  Regulation of the human C-reactive protein gene in transgenic mice.

Authors:  C Murphy; J Beckers; U Rüther
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

9.  The major receptor for C-reactive protein on leukocytes is fcgamma receptor II.

Authors:  D Bharadwaj; M P Stein; M Volzer; C Mold; T W Du Clos
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

10.  THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : I. DISTRIBUTION OF THE REACTIVE PROTEIN IN PATIENTS' SERA AND THE EFFECT OF CALCIUM ON THE FLOCCULATION REACTION WITH C POLYSACCHARIDE OF PNEUMOCOCCUS.

Authors:  T J Abernethy; O T Avery
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

View more
  23 in total

1.  Mixed effects of caffeic acid phenethyl ester (CAPE) on joint inflammation, bone loss and gastrointestinal inflammation in a murine model of collagen antibody-induced arthritis.

Authors:  Bonnie Williams; Eleni Tsangari; Romany Stansborough; Victor Marino; Melissa Cantley; Anak Dharmapatni; Rachel Gibson; Egon Perilli; Tania Crotti
Journal:  Inflammopharmacology       Date:  2017-01-03       Impact factor: 4.473

2.  Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice.

Authors:  Nicholas R Jones; Melissa A Pegues; Mark A McCrory; Steven W Kerr; Huiping Jiang; Rosemarie Sellati; Valentina Berger; Jorge Villalona; Rajvee Parikh; Mary McFarland; Lynn Pantages; Jeffrey B Madwed; Alexander J Szalai
Journal:  Arthritis Rheum       Date:  2011-09

3.  C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes.

Authors:  F Liu; H Y Chen; X R Huang; A C K Chung; L Zhou; P Fu; A J Szalai; H Y Lan
Journal:  Diabetologia       Date:  2011-07-09       Impact factor: 10.122

4.  Chronic insulin therapy reduces adipose tissue macrophage content in LDL-receptor-deficient mice.

Authors:  J Yoon; S Subramanian; Y Ding; S Wang; L Goodspeed; B Sullivan; J Kim; K D O'Brien; A Chait
Journal:  Diabetologia       Date:  2011-02-17       Impact factor: 10.122

5.  Inhibition of Experimental Autoimmune Encephalomyelitis in Human C-Reactive Protein Transgenic Mice Is FcγRIIB Dependent.

Authors:  Xian-Zhen Hu; Tyler T Wright; Nicholas R Jones; Theresa N Ramos; Gregory A Skibinski; Mark A McCrory; Scott R Barnum; Alexander J Szalai
Journal:  Autoimmune Dis       Date:  2010-10-12

6.  Serum amyloid A3 does not contribute to circulating SAA levels.

Authors:  Tsuyoshi Chiba; Chang Yeop Han; Tomas Vaisar; Kentaro Shimokado; Atil Kargi; Mei-Hsiu Chen; Shari Wang; Thomas O McDonald; Kevin D O'Brien; Jay W Heinecke; Alan Chait
Journal:  J Lipid Res       Date:  2009-03-12       Impact factor: 5.922

7.  Neointimal formation is reduced after arterial injury in human crp transgenic mice.

Authors:  Haim D Danenberg; Etty Grad; Rajesh V Swaminathan; Zhiping Chen; Philip Seifert; Alexander J Szalai; Chaim Lotan; Daniel I Simon; Elazer R Edelman
Journal:  Atherosclerosis       Date:  2008-02-13       Impact factor: 5.162

8.  Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent.

Authors:  Dongqi Xing; Fadi G Hage; Yiu-Fai Chen; Mark A McCrory; Wenguang Feng; Gregory A Skibinski; Erum Majid-Hassan; Suzanne Oparil; Alexander J Szalai
Journal:  Am J Pathol       Date:  2007-12-06       Impact factor: 4.307

Review 9.  Estrogen and mechanisms of vascular protection.

Authors:  Dongqi Xing; Susan Nozell; Yiu-Fai Chen; Fadi Hage; Suzanne Oparil
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-16       Impact factor: 8.311

10.  Genetic ablation of C-reactive protein gene confers resistance to obesity and insulin resistance in rats.

Authors:  Mengliu Yang; Sheng Qiu; Yirui He; Ling Li; Tong Wu; Ning Ding; Fanghong Li; Allan Z Zhao; Gangyi Yang
Journal:  Diabetologia       Date:  2021-02-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.